| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/29/2005 | US20050215455 Surfactants in powdered form that can be used in tablets or gelatin capsules; preparation process and compositions containing them |
| 09/29/2005 | US20050215454 providing a starting mixture comprising an alk(en)yl polyglycoside, and one or more fatty alcohols, reacting starting mixture with a compound selected from omega -halocarboxylic acids, omega -halocarboxylic acid salts, omega -halocarboxylic acid esters or mixture to perform esterification |
| 09/29/2005 | US20050215451 Powdery product comprising crystalline beta-maltose monohydrate, its preparation, and uses |
| 09/29/2005 | US20050215438 Gravel pack comprising aqueous-based component, viscosifier (polyacrylic acid, polybutadiene block copolymers), encapsulated pH adjusting agent (sodium hydroxide), base-releasing material or acid-releasing material, and gravel particles, for treating subterranean formations |
| 09/29/2005 | US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter |
| 09/29/2005 | US20050214424 Sugar-free hard coatings prepared from liquid maltitol comprising dp4+fraction |
| 09/29/2005 | US20050214392 Treatments for immune systems disorders |
| 09/29/2005 | US20050214391 Method and composition for the treatment of dermatologic diseases |
| 09/29/2005 | US20050214388 Multivitamin formulations containing controlled-release magnesium |
| 09/29/2005 | US20050214387 Low-dose potassium supplementation for the prevention and treatment of hypertension |
| 09/29/2005 | US20050214382 Zinc preservative composition and method of use |
| 09/29/2005 | US20050214380 Nanobioprocessor for protein and cell therapy |
| 09/29/2005 | US20050214379 Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| 09/29/2005 | US20050214378 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 09/29/2005 | US20050214377 Microparticles for cell delivery |
| 09/29/2005 | US20050214376 Hydrogel-containing medical articles and methods of using and making the same |
| 09/29/2005 | US20050214375 Process for producing block copolymer/drug composite |
| 09/29/2005 | US20050214373 Coated tablet formulation and method |
| 09/29/2005 | US20050214372 Stable pharmaceutical composition comprising an acid labile drug |
| 09/29/2005 | US20050214371 Stable pharmaceutical composition comprising an acid labile drug |
| 09/29/2005 | US20050214370 Stable coating agent comprising sterol |
| 09/29/2005 | US20050214369 Lecithin-containing granular compositions and methods of their preparation |
| 09/29/2005 | US20050214368 Controlled release formulations using intelligent polymers |
| 09/29/2005 | US20050214367 Processes for making coated phytochemicals and tocopherols and products formed therefrom |
| 09/29/2005 | US20050214365 Taste, texture; no water required; formulated using Pharmaburst (TM) proprietary disintegrant with talc, sodium stearyl fumarate, magnesium stearate and silicon dioxide as lubricants, potassium acesulfate sweetner, anise and mint flavors |
| 09/29/2005 | US20050214364 Products and methods for treating vaginal infections |
| 09/29/2005 | US20050214363 Administering an immediate release oral dosage of diclofenac or in salt form together with one or more alkali metal bicarbonates in an amount of >20% by weight; palatable and free from any unpleasant taste or side effects; short time to the maximum plasma concentration; high maximum plasma concentration |
| 09/29/2005 | US20050214362 Appetite suppressant |
| 09/29/2005 | US20050214361 Shell contains non-water-soluble light-shielding agent, with medicine encapsulated within |
| 09/29/2005 | US20050214360 Diclofenac sodium oral pharmaceutical |
| 09/29/2005 | US20050214359 Co-micelles; membrane proteins; for intranasal delivery; influenza hemagglutinin protein; neuramimidases |
| 09/29/2005 | US20050214358 Fatty acid binding proteins; synthetic milk; for promoting mammalian pheromone receptor expression |
| 09/29/2005 | US20050214357 Phospholipids bilayer and aqueous core, hydrophobic drug, vitamin E derivative, and phosphatidyl choline; sonication; homogenization; increased encapsulation efficiency |
| 09/29/2005 | US20050214356 Self assembling activation agents targeted using active drug release |
| 09/29/2005 | US20050214355 Sterically stabilized cationic liposomes (SSCL) encapsulating K type oligodeoxynucleotide (ODN) including CpG motif; interleukins; fusion proteins; immunology; antitumor agents |
| 09/29/2005 | US20050214354 Stabilized methylphenidate; acrylonitrile-methyl acrylate copolymer; child-proof plastic wrapped packages/pouches |
| 09/29/2005 | US20050214353 Matrix for administering ergoline compounds such as lisuride; restless leg syndrome; circadian rhythm disorders; Parkinson's disease |
| 09/29/2005 | US20050214352 Patch and process for producing the same |
| 09/29/2005 | US20050214351 Wound dressings; discourages animal from removing bandage with its teeth |
| 09/29/2005 | US20050214350 Antimicrobial sheets for environmental and human protection and prevention |
| 09/29/2005 | US20050214334 Composition for topical substance delivery |
| 09/29/2005 | US20050214333 Cosmetic with sensitive ingredients |
| 09/29/2005 | US20050214331 Pharmaceutical compositions for bioactive peptide agents |
| 09/29/2005 | US20050214330 Process for producing sustained-release composition |
| 09/29/2005 | US20050214327 Neurotoxin-containing suppositories and related methods |
| 09/29/2005 | US20050214326 Amino acid and zinc containing botulinum toxin pharmaceutical compositions |
| 09/29/2005 | US20050214318 Immunogenic composition and method of developing a vaccine based on fusion protein |
| 09/29/2005 | US20050214317 A binding site of the cystosolic protein cyclophilin A on human immunodeficiency virus capsid protein, which may be expressed by a recombinant viral, bacterial or yeast carrier; may be treated with neuraminidase or trypsin to remove sialic acid; immune stimulant such as teichoic acid or zymosan |
| 09/29/2005 | US20050214278 Antibody-containing solution pharmaceuticals |
| 09/29/2005 | US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 09/29/2005 | US20050214251 Stability and rapid onset of action; may be administered via buccal administration, sublingual administration, pulmonary delivery, nasal administration, subcutaneous administration, rectal administration, vaginal administration, or ocular administration |
| 09/29/2005 | US20050214244 Menopause homeopathic formulations |
| 09/29/2005 | US20050214229 Two-stage transmucosal medicine delivery system for symptom relief |
| 09/29/2005 | US20050214228 Uniform powder production; controlling relative stream velocity, solution concentration and proportion of solvent to antisolvent; preventing liquid inclusion |
| 09/29/2005 | US20050214227 Needleless syringe dosage formulations |
| 09/29/2005 | US20050214226 Spraying onto medium cooled below solidification temperature of expansion agent; creating surface ruptures; economic, simple, industrial scale; precise control of physical characteristics |
| 09/29/2005 | US20050214225 Flushing away allergens, microbes, mucosal by products and dust particles; syringe injecting aqueous saline solution containing sesame oil combined with peppermint and/or eucalyptus oil; promoting healing after surgery; simple, low cost |
| 09/29/2005 | US20050214224 Lipid formulations for spontaneous drug encapsulation |
| 09/29/2005 | US20050214223 Abuse-safeguarded dosage form |
| 09/29/2005 | US20050214216 Diagnostic microspheres |
| 09/29/2005 | US20050211725 Platen pump |
| 09/29/2005 | US20050211244 drugs having microstructure particle sizes, adapted for use in metered dosage containers for prolonged delivery inhalers |
| 09/29/2005 | DE4318141B4 Wirkstofftuch Drug cloth |
| 09/29/2005 | DE19810951B4 Verwendung eines textilen Materials als transdermales Abgabesystem sowie Verfahren zu seiner Herstellung Use of a textile material as a transdermal delivery system and to processes for its preparation |
| 09/29/2005 | DE10361596A1 Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform A process for preparing a secured against abuse dosage form |
| 09/29/2005 | DE102004011686A1 Dermales oder transdermales therapeutisches System mit Matrixbestandteil aus nachwachsendem Rohrstoff Dermal or transdermal therapeutic system with matrix component from a renewable fuel pipe |
| 09/29/2005 | DE102004011663A1 Erythropoietin-Flüssigformulierung Erythropoietin liquid formulation |
| 09/29/2005 | CA2562388A1 Emulsion-stabilized preparation |
| 09/29/2005 | CA2560959A1 Method of producing coated fine particles |
| 09/29/2005 | CA2560303A1 Native plant cell wall compositions and methods of use |
| 09/29/2005 | CA2560298A1 Preparation with elevated content |
| 09/29/2005 | CA2560226A1 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient |
| 09/29/2005 | CA2560024A1 Intranasal benzodiazepine compositions |
| 09/29/2005 | CA2559915A1 Micronization of pharmaceutically active agents |
| 09/29/2005 | CA2559722A1 Administration of cisplatin by inhalation |
| 09/29/2005 | CA2559579A1 Thermoplastic films and methods for making |
| 09/29/2005 | CA2559520A1 Anti-adhesion spraying |
| 09/29/2005 | CA2559477A1 Process for the production of cs particles and microcapsules using porous templates, cs particles and microcapsules, and use thereof |
| 09/29/2005 | CA2559227A1 Pharmaceutical formulations |
| 09/29/2005 | CA2559176A1 A disposable nonwoven mitt |
| 09/29/2005 | CA2559161A1 Irna agents targeting vegf |
| 09/29/2005 | CA2558730A1 Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances |
| 09/29/2005 | CA2558254A1 Cream-gel containing ivermectin |
| 09/29/2005 | CA2557833A1 Emulsion of fluorocarbon compounds for medical purposes and method for production thereof |
| 09/29/2005 | CA2557795A1 Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose |
| 09/29/2005 | CA2555363A1 Coenzyme q compositions persisting in blood |
| 09/29/2005 | CA2554018A1 Lyophilization method to improve excipient crystallization |
| 09/28/2005 | EP1580229A1 Biopolymer compositons and products thereof |
| 09/28/2005 | EP1580218A1 Complex emulsions of perfluoropolyethers |
| 09/28/2005 | EP1579877A1 Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
| 09/28/2005 | EP1579857A1 Chemically stable compositions of 4-hydroxy tamoxifen |
| 09/28/2005 | EP1579855A1 Novel dry powder inhalation system for transpulmonary administration |
| 09/28/2005 | EP1579854A1 Dermal or transdermal therapeutic system comprising a matrix with a renewable raw material |
| 09/28/2005 | EP1579853A2 Sustained release dosage form having latex coating and method of making the same |
| 09/28/2005 | EP1579852A2 Drug carrier pellet production process |
| 09/28/2005 | EP1579851A2 Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of use thereof |
| 09/28/2005 | EP1579850A2 A pharmaceutical composition containing liposomes for treating a cancer |
| 09/28/2005 | EP1579822A2 Dental floss head device with a flavor delivery means |
| 09/28/2005 | EP1579771A1 Water-based shellac coating material, process for producing the same, coated food obtained with the coating material, process for producing the same, coated medicine, process for producing the same, glazing composition for oily snack, method of glazing, and glazed oily snack |
| 09/28/2005 | EP1579506A2 Water soluble metal and semiconductor nanoparticle complexes |